- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Embecta Corp (EMBC)
Assess today's live Embecta Corp (EMBC) share price, performance and insights using our live NASDAQ: EMBC stock exchange data.
Analyse the historical data and Embecta Corp share price performance charts on this page. Our technical summary section provides analysis on Embecta share price buy/sell indicators using real-time data (or discuss the Embecta (EMBC) stock price today with other investors in the Embecta NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ EMBC share price (ISIN: US29082K1051) to enhance your trading decisions with our free investment tools and resources.
What Is the Embecta Corp Share Price Today?
The Embecta share price today is 3.93.
What Is the Stock Symbol for Embecta Corp
The stock symbol (or 'ticker') for Embecta Corp is "EMBC."
What Stock Exchange Does Embecta Corp Trade On?
Embecta Corp is listed and trades on the NASDAQ stock exchange.
Is Embecta Corp a Good Stock to Buy?
Determining whether Embecta Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Embecta Corp share price performance charts on this page. Our technical summary section provides analysis on Embecta share price buy/sell indicators using real-time data (or discuss the Embecta (EMBC) stock price today with other investors in the Embecta NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ EMBC share price (ISIN: US29082K1051) to enhance your trading decisions with our free investment tools and resources.
What Is the Embecta Corp Share Price Today?
The Embecta share price today is 3.93.
What Is the Stock Symbol for Embecta Corp
The stock symbol (or 'ticker') for Embecta Corp is "EMBC."
What Stock Exchange Does Embecta Corp Trade On?
Embecta Corp is listed and trades on the NASDAQ stock exchange.
Is Embecta Corp a Good Stock to Buy?
Determining whether Embecta Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
4.03
+0.13(+3.22%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.82
4.06
52 wk Range
3.82
15.55
Trading near 52-week Low
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.824.06
52 wk Range
3.8215.55
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(15.38%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(15.38%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EMBC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
15.00
Upside
+272.21%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
2 Hold
1 Sell
Ratings:
4 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 15.00
(+272.21% Upside)
Embecta Corp Earnings Call Summary for Q2/2026
- Embecta Q2 FY2026 EPS of $0.27 missed estimates by 35.71%; revenue of $221.8M fell short by 5.88%, triggering 44% stock plunge to $5.15.
- U.S. market revenue plummeted 29.4% YoY in adjusted constant currency, driving overall 14.4% revenue decline and GAAP net loss of $4.1M.
- Company revised full-year guidance downward amid competitive pressures in pen needle and syringe markets; initiating cost and organizational review.
- Strategic focus on Owen Mumford acquisition to expand portfolio, brand transition initiatives, and product development to regain market position.
- Despite challenges, stock trades at 4.47 P/E with 6.49% dividend yield; InvestingPro notes 38% free cash flow yield and 'GREAT' financial health score.
Last Updated: 05/05/2026, 14:04
Read Full TranscriptEarnings
Latest Release
05/05/2026
EPS / Forecast
0.27 / 0.42
Revenue / Forecast
221.8M / 235.66M
Compare EMBC to Peers and Sector
Metrics to compare | EMBC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEMBCPeersSector | |
|---|---|---|---|---|
P/E Ratio | 1.7x | 16.0x | −0.5x | |
PEG Ratio | 0.01 | 0.08 | 0.00 | |
Price/Book | −0.4x | 1.3x | 2.6x | |
Price / LTM Sales | 0.2x | 1.8x | 3.2x | |
Upside (Analyst Target) | 207.7% | 46.5% | 47.8% | |
Fair Value Upside | Unlock | 7.7% | 5.9% | Unlock |
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Embecta (NASDAQ: EMBC) Share Price Today?
The Embecta stock price today is 4.03 USD.
What Stock Exchange Does Embecta (EMBC) Trade On?
Embecta is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Embecta?
The stock symbol (also called a 'ticker') for Embecta is "EMBC."
Does Embecta Pay Dividends? What’s The Current EMBC Dividend Yield?
Yes, EMBC Pays Dividends to its Shareholders. The current Embecta dividend yield is 15.38%.
What Is the Current Embecta Market Capitalisation?
As of today, Embecta (NASDAQ: EMBC) market cap is 231.38M USD.
What Is Embecta's (EMBC) Earnings Per Share (TTM)?
The Embecta EPS is currently 2.38 (Trailing Twelve Months).
When Is the Next Embecta Earnings Date?
Embecta's next earnings report will be released on 07/08/2026.
Is EMBC a Buy or Sell From a Technical Analyst Perspective?
Based on today's Embecta moving averages and other technical indicators, the daily buy/sell signal for EMBC stock is Strong Sell.
How Many Times Has Embecta Stock Split?
Embecta has split 0 times. (See the EMBC stock split history page for full effective split date and price information.)
How Many Employees Does Embecta Have?
Embecta has 1850 employees, based on their latest Companies House report.
What is the current trading status of Embecta (NASDAQ: EMBC)?
As of 06/05/2026, Embecta (EMBC) is trading at a share price of 4.03 USD, with a previous close of 3.90 USD. The stock has fluctuated within a day range of 3.82 USD to 4.06 USD, while its 52-week range spans from 3.82 USD to 15.55 USD.
What Is Embecta (EMBC) Price Target According to Analysts?
The average 12-month price target for Embecta is 15.00 USD, with a high estimate of 22 USD and a low estimate of 11 USD. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +272.21% Upside potential.
What Is the EMBC Premarket Price?
EMBC's last pre-market stock price is 4.00 USD. The pre-market share volume is 246,750.00, and the stock has decreased by 0.10, or 2.56%.
What Is the EMBC After Hours Price?
EMBC's last after hours stock price is 3.97 USD, the stock has decreased by 0.07, or 1.79%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.